Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 03:50PM GMT
Release Date Price: $154.57 (+8.19%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Okay. Great. We're going to go ahead and kick it off. I'm Tycho Peterson from the Life Sciences team. It's my pleasure to introduce our next company this morning, Guardant. (Operator Instructions)

And with that, I'll turn it over to Helmy.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

Thank you, Tycho, for the opportunity to present today at the conference. Okay. If we can bring the presentation on. Very good. Well, next slide. Please note our forward-looking statement. Next.

A little less than a decade ago, we had a dream that liquid biopsies could be at the center of transforming cancer care across the entire continuum from early cancer screening to recurrence monitoring and to therapy selection, bringing to clinical practice, a powerful new precision oncology paradigm.

Indeed, we believe that liquid biopsies could serve as a driving force to unlocking critical data that could accelerate our collective understanding of how

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot